Clinical Trial Update: Intranasal Vasopressin Treatment in Children With Autism [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating intranasal vasopressin in children with autism has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Vasopressin (intranasal) (vasopressin)

Snippet

Sponsor: Stanford University | Conditions: Autism, Autism Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-09-19